Chronic Pain and Transcranial Direct Current Stimulation in Clinical Settings

Chronic Pain Clinical Trial

Official title:

Reduce Chronic Pain With Transcranial Direct Current Stimulation in Clinical Settings

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04726423
• Other study ID #: 2020-3273-PA
• Status: Recruiting
• Start date: January 4, 2021
• Est. completion date: December 2023

Study information

• Verified date: July 2023
• Source: Université de Sherbrooke
• Contact: Guillaume Leonard, PhD
• Phone: 1 819-780-2220
• Email: guillaume.leonard2[@]usherbrooke.ca
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Physical exercises and transcranial direct current stimulation (tDCS) are both known to reduce chronic pain in structured laboratory studies. The aim of this study is to assess the efficacy of this combined treatment in clinical settings.

Description:

Chronic pain patients who are going to the physiotherapy clinic to receive tDCS treatment sessions are evaluated in order to assess the efficacy of tDCS in clinical settings. Physiotherapists prescribe physical exercises adapted to the patients conditions. Patients performed their physical exercises every time they received a tDCS treatment, but were also recommended to continue their physical exercises program at home after completion of physiotherapy visits.

Concerning tDCS treatment, patients were encouraged to receive 1 tDCS session per day for 5 consecutive days.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: December 2023
• Est. primary completion date: February 4, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• To have chronic pain

Exclusion Criteria:

• Contraindication to tDCS

Related Conditions & MeSH terms

• Chronic Pain

Intervention

Other:
• transcranial direct current stimulation
5 daily sessions of tDCS (2mA, 20 min) were recommended to all patients. Physical exercises were also done at the physiotherapy clinic. Physical exercises program was recommended to be continued at home after the week of physiotherapy visits.

Locations

Country	Name	City	State
Canada	Physio-Atlas	Sherbrooke	Quebec

Sponsors (1)

Lead Sponsor	Collaborator
Université de Sherbrooke

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in McGill pain Questionnaire	qualitative and quantitative aspects of pain	Baseline, 1 week, 1 month
Primary	Change in Brief Pain Inventory	Physical Function	Baseline, 1 week, 1 month
Primary	Change in Tampa Questionnaire	Kinesiophobia	Baseline, 1 week, 1 month
Primary	Change in Beck Depression Inventory	Depression	Baseline, 1 week, 1 month
Primary	Change in Patient global impression of change	Impression of change	1 week, 1 month
Secondary	Number of sessions received	Feasibility; did the patients received all their tDCS sessions in 5 days (1 per day)	Through study completion, an average of 5 days
Secondary	Side effect	Side effect reported by the patients (headache, dizziness, fatigue, nausea, redness, tingling)	Through study completion, an average of 5 days